19 June 2013
Keywords: merck, co, stops, taranabant, ph, iii, drug
Article | 13 October 2008
US drug major Merck & Co has discontinued the development of taranabant, after the obesity drug showed disappointing efficacy in a
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 October 2008
© 2013 thepharmaletter.com